Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share (Tables)

v3.23.1
Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
Basic and diluted loss per share (“EPS”) were as follows:
Three Months Ended
March 31,
$ in thousands, except share and per share data 2023 2022
Numerator:
Net loss $ (10,544) $ (58,968)
Denominator:
Weighted-average common shares outstanding 194,650,065  183,949,912 
Weighted-average impact of warrants (1)
2,249,227  81,103 
Denominator for basic EPS – weighted-average shares
196,899,292  184,031,015 
Effect of dilutive securities
—  — 
Denominator for diluted EPS – weighted-average shares
196,899,292  184,031,015 
EPS – Basic and Diluted
$ (0.05) $ (0.32)
________________
(1)Warrants that have a $0.01 exercise price are assumed to be exercised when vested because common shares issued for little consideration upon exercise are included in outstanding shares for the purposes of computing basic and diluted EPS.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following securities were excluded from the calculation of loss per share as their impact would be anti-dilutive:
Three Months Ended
March 31,
2023 2022
Stock options 19,533,368  37,429,240 
Shares issuable related to the employee stock purchase plan 440,502  — 
Unvested restricted stock units 11,770,288  — 
Restricted shares issued upon the early exercise of unvested stock options 50,331  5,150,369 
Unvested warrants 2,312,026  — 
Vested warrants 8,566,656  8,566,666